Form D · Biotechnology
MicroByre, Inc.
Berkeley, CA · CIK 0001776546
Offering snapshot reported Jan 24, 2022 · SEC filing
- Reported sold
- $10.7M Offering amount: $15.7M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 7, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2022 | Initial | $10,698,327 | No comparison | 11 | SEC filing |
| Oct 21, 2021 | Amendment | $2,497,565 | $329,999vs Sep 8, 2020 | 9 | SEC filing |
| Sep 8, 2020 | Initial | $2,167,566 | No comparison | 8 | SEC filing |
| May 10, 2019 | Initial | $2,899,999 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-430609
Source: Form D, filed Jan 24, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Anderson | Director, Executive |
| Matthew Nordan | Director |
| Sarah Richardson | Director, Executive |
| Rik Wehbring | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
813 Heinz Ave
Berkeley, CA, 94710
Berkeley, CA, 94710